Glucovision (2014-06-19)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 140616FDG-2 | Glucovision | - Recalling Firm
- Centre for Probe Development and Commercialization (CPDC)
- 1280 Main St. W. NRB-A316
- Hamilton
- L8S 4K1
- Ontario
- CANADA
- Marketing Authorization Holder
- Not Applicable
| Glass Vials | No market authorization | 37 [F-18]-Fludeoxyglucose (FDG) Phosphate/vial |
Recalled Products
Glucovision
Out of specification result for sterility test.
1 hospital and 1 clinic in Ontario